Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
FDA removes partial clinical hold on Cell Therapeutics' Tosedostat aminopeptidase inhibitor

FDA removes partial clinical hold on Cell Therapeutics' Tosedostat aminopeptidase inhibitor

Alliance for Cancer Gene Therapy grants nearly $25M to conduct cancer related gene therapy research

Alliance for Cancer Gene Therapy grants nearly $25M to conduct cancer related gene therapy research

Scientists obtain detailed molecular structure of member of Tet family of enzymes

Scientists obtain detailed molecular structure of member of Tet family of enzymes

Scientists find inhibiting action of BRD4 protein may eradicate rare type of soft-tissue cancer

Scientists find inhibiting action of BRD4 protein may eradicate rare type of soft-tissue cancer

Fluidigm announces universal sample prep workflow for single-cell DNA sequencing

Fluidigm announces universal sample prep workflow for single-cell DNA sequencing

Engineered immune cells show antitumor activity in two patients with advanced cancers

Engineered immune cells show antitumor activity in two patients with advanced cancers

Key questions to ask about bone marrow transplants

Key questions to ask about bone marrow transplants

Experimental drug inhibits BTK molecule in patients with chronic lymphocytic leukemia

Experimental drug inhibits BTK molecule in patients with chronic lymphocytic leukemia

EORTC, GIMEMA clinical trial results show high-dose cytarabine improves outcome in AML patients

EORTC, GIMEMA clinical trial results show high-dose cytarabine improves outcome in AML patients

BioLineRx enrolls first patient in BL-7010 Phase 1/2 trial for treatment of celiac disease

BioLineRx enrolls first patient in BL-7010 Phase 1/2 trial for treatment of celiac disease

Researchers discover control mechanism that can trigger development of MDS

Researchers discover control mechanism that can trigger development of MDS

Researchers discover direct evidence of genetic overlap between cognitive ability and schizophrenia

Researchers discover direct evidence of genetic overlap between cognitive ability and schizophrenia

Epsilon inks multi-year renewal, expansion agreements with The Leukemia & Lymphoma Society

Epsilon inks multi-year renewal, expansion agreements with The Leukemia & Lymphoma Society

Preclinical data shows BGB324 as potential treatment option for Chronic Myeloid Leukemia

Preclinical data shows BGB324 as potential treatment option for Chronic Myeloid Leukemia

New report shows death rates for lung cancer dropping at a faster pace

New report shows death rates for lung cancer dropping at a faster pace

Scientists continue work to end chemotherapy pain

Scientists continue work to end chemotherapy pain

BioLineRx reports promising initial results from Phase 2 trial of BL-8040 in AML patients

BioLineRx reports promising initial results from Phase 2 trial of BL-8040 in AML patients

Dasatinib+letrozole improves survival for women with hormone receptor-positive, HER2-negative metastatic breast cancer

Dasatinib+letrozole improves survival for women with hormone receptor-positive, HER2-negative metastatic breast cancer

Researchers discover completely new targets for treatment of blood cancers

Researchers discover completely new targets for treatment of blood cancers

Novel ISM strategy enables selection of potentially effective cancer therapies for patients

Novel ISM strategy enables selection of potentially effective cancer therapies for patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.